746 related articles for article (PubMed ID: 29602754)
21. Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence.
Mir H; Siemieniuk RAC; Ge L; Foroutan F; Fralick M; Syed T; Lopes LC; Kuijpers T; Mas JL; Vandvik PO; Agoritsas T; Guyatt GH
BMJ Open; 2018 Jul; 8(7):e023761. PubMed ID: 30049703
[TBL] [Abstract][Full Text] [Related]
22. Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials.
Garg A; Thawabi M; Rout A; Sossou C; Cohen M; Kostis JB
Cardiology; 2019; 144(1-2):40-49. PubMed ID: 31574522
[TBL] [Abstract][Full Text] [Related]
23. Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses.
Udell JA; Opotowsky AR; Khairy P; Silversides CK; Gladstone DJ; O'Gara PT; Landzberg MJ
Can J Cardiol; 2014 Oct; 30(10):1216-24. PubMed ID: 25154803
[TBL] [Abstract][Full Text] [Related]
24. Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta-Analysis, and New Insights From the CLOSE Study.
Turc G; Calvet D; Guérin P; Sroussi M; Chatellier G; Mas JL;
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29910193
[TBL] [Abstract][Full Text] [Related]
25. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
26. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials.
Vidale S; Russo F; Campana C; Agostoni E
Angiology; 2019 Apr; 70(4):325-331. PubMed ID: 30270651
[TBL] [Abstract][Full Text] [Related]
27. Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated systematic review and meta-analysis.
Goel S; Patel S; Zakin E; Pasam RT; Gotesman J; Malik BA; Ayzenberg S; Frankel R; Shani J
Indian Heart J; 2019; 71(6):446-453. PubMed ID: 32248916
[TBL] [Abstract][Full Text] [Related]
28. Patent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke: An update meta-analysis of randomized controlled trials.
Ma Y; Li D; Bai F; Qin F; Li J; Li Y; Liu N; Xie H; Zhou S; Liu Q
Medicine (Baltimore); 2018 Aug; 97(34):e11965. PubMed ID: 30142823
[TBL] [Abstract][Full Text] [Related]
29. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.
Mirzaali M; Dooley M; Wynne D; Cooter N; Lee L; Haworth P; Saha R; Gainsborough N; Hildick-Smith D
Catheter Cardiovasc Interv; 2015 Nov; 86(6):1078-84. PubMed ID: 26105198
[TBL] [Abstract][Full Text] [Related]
30. Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis.
Vukadinović D; Schirmer SH; Vukadinović AN; Ukena C; Scheller B; Mahfoud F; Böhm M
Clin Res Cardiol; 2019 Feb; 108(2):157-166. PubMed ID: 30051178
[TBL] [Abstract][Full Text] [Related]
31. Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke: A Systematic Review and Meta-analysis.
Shah R; Nayyar M; Jovin IS; Rashid A; Bondy BR; Fan TM; Flaherty MP; Rao SV
Ann Intern Med; 2018 Mar; 168(5):335-342. PubMed ID: 29310136
[TBL] [Abstract][Full Text] [Related]
32. Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated meta-analysis.
Xu HB; Zhang H; Qin Y; Xue F; Xiong G; Yang L; Bai H; Wu J
J Neurol Sci; 2018 Jul; 390():139-149. PubMed ID: 29801875
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.
Zhang XL; Kang LN; Wang L; Xu B
BMC Cardiovasc Disord; 2018 Mar; 18(1):45. PubMed ID: 29499641
[TBL] [Abstract][Full Text] [Related]
34. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
[TBL] [Abstract][Full Text] [Related]
35. Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials.
Nagaraja V; Raval J; Eslick GD; Burgess D; Denniss AR
Heart Lung Circ; 2013 Nov; 22(11):903-9. PubMed ID: 24035325
[TBL] [Abstract][Full Text] [Related]
36. Patent foramen ovale closure to prevent secondary neurologic events.
Jasper R; Blankenship JC
Eur J Intern Med; 2017 Oct; 44():1-11. PubMed ID: 28684051
[TBL] [Abstract][Full Text] [Related]
37. Closure versus Medical Therapy for Patent Foramen Ovale in Patients with Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials.
Qiu B; Cai Y; Wang D; Lin J; Fan Y
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3463-3472. PubMed ID: 30185398
[TBL] [Abstract][Full Text] [Related]
38. Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.
Kent DM; Dahabreh IJ; Ruthazer R; Furlan AJ; Reisman M; Carroll JD; Saver JL; Smalling RW; Jüni P; Mattle HP; Meier B; Thaler DE
J Am Coll Cardiol; 2016 Mar; 67(8):907-917. PubMed ID: 26916479
[TBL] [Abstract][Full Text] [Related]
39. Updated meta-analysis of closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
Nasir UB; Qureshi WT; Jogu H; Wolfe E; Dutta A; Majeed CN; Tan WA
Cardiovasc Revasc Med; 2019 Mar; 20(3):187-193. PubMed ID: 30905408
[TBL] [Abstract][Full Text] [Related]
40. The Closure of Patent Foramen Ovale in Preventing Subsequent Neurological Events: A Bayesian Network Meta-Analysis to Identify the Best Device.
Varotto L; Bregolin G; Paccanaro M; De Boni A; Bonanno C; Perini F
Cerebrovasc Dis; 2020; 49(2):124-134. PubMed ID: 32289794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
